Introducing a way for you to connect, learn and train digitally with leading ophthalmologists. Let us know what topics interest you.

Contact us


Introducing a way for you to connect, learn and train digitally with leading ophthalmologists. Let us know what topics interest you.

Contact us




Making DMEK better: The preloaded Modified Jones Tube

Presenter: Evan Pike, MD

DMEK has shown exceptional outcomes in patients, but the surgical learning curve can be steep for surgeons. One obstacle is the tedious preparation of a very fragile and finicky DMEK graft. With the availability of preloaded DMEK in the Modified Jones Tube, surgeons' manipulation of the graft in the OR is minimal and efficient, allowing for a safer and smoother procedure.

Assessing prevalence of SARS-CoV-2 in human postmortem ocular tissues and impact of routine COVID-19 testing for cornea donors

Presenter: Onkar B. Sawant, PhD, Eversight Director of Research & Michael Titus, CEBT, Eversight Vice President of Clinical Operations

Eversight-led research confirms a small but noteworthy prevalence rate of SARS-CoV-2 in postmortem ocular tissues. This presentation by Eversight Director of Research Onkar B. Sawant, PhD, will dive into the background, methods, findings and interpretations of this ongoing, collaborative investigation with researchers from Eversight, Wayne State University, Kellogg Eye Center and Rush University. Their paper—Prevalence of SARS-CoV-2 in human post-mortem ocular tissues—was recently published in The Ocular Surface and findings were also presented at the 2020 Cornea and Eye Banking Forum.

Eversight Vice President of Clinical Operations Michael Titus, CEBT, will also explore the impact of the COVID-19 pandemic on eye banking operations and Eversight's response to provide safe donor eye tissues through donor screening, infection prevention protocols and postmortem SARS-CoV-2 testing.

Clinical Management of HSV Keratitis & Preventing Infection at Tissue Procurement

Presenters: Mohammad H. Dastjerdi, MD, & Onkar B. Sawant, PhD, Eversight Director of Research

In the first half of this webinar, Dr. Dastjerdi will cover the epidemiology, clinical manifestations, diagnosis, treatment, corneal complications and prevention of reactivation of herpes simplex virus. In the second half, Dr. Sawant will present data on the Effect of a Second Betadine Exposure on Corneal Toxicity to Decrease Donor Tissue Fungal Bioburden—an abstract detailing the benefits of Eversight's rigorous infection prevention protocol at the time of tissue procurement.

Taking control of the situation: Reconstructing the anterior chamber with the artificial iris in DMEK surgery

Presenter: Donald Tan, MD

This session introduces a novel approach to utilize the artificial iris to restore anterior chamber (AC) anatomy, so as to facilitate DMEK surgery in complex cases of bullous keratopathy, glaucoma, or previous failed grafts. The main concept is one of enhancing surgical control of the donor tissue and the anterior chamber. Enhanced donor control can be achieved using the pull-through technique, while surgical control of the DMEK AC environment is to restore the anatomical architecture of the AC, including restoration of the angles by synechiolysis, removal of abnormal and non-functional iris, restoration of the lens-iris diaphragm through stabilization of a posterior chamber IOL, and fixation of the CustomFlex Artificial Iris, prior to DMEK surgery.

Identification and management of limbal stem cell deficiency

Presenter: Jeffrey Goshe, MD

The program focuses on the pathophysiology, assessment, and management of limbal stem cell deficiency.

Impact of COVID-19 on ocular disease and donor tissue

Presenter: Michael Titus, CEBT, Eversight VP of Clinical Operations & Shahzad I. Mian, MD

Dr. Mian will explore the impact of COVID-19 on ocular disease and Michael Titus will discuss Eversight's ongoing work to provide safe donor eye tissue. Come prepared with questions for this interactive webinar.

Restart your practice with an effective patient communication plan

Presenter: Jill Maher, MA, COE & Ryan Schumacher

Learn what information your patients need to know and best practices for patient communication across your marketing channels. Attendees will also receive a free patient communication plan that can be tailored to your practice.

DALK pearls

Presenter: Nambi Nallasamy, MD

Adding DALK to your repertoire can increase options for your patients. We will review indications and contraindications for DALK, different approaches to the procedure and how to handle the unique complications that can arise with DALK.

Keratoprosthesis in corneal blindness

Presenter: M. Soledad Cortina, MD

This presentation will discuss the role of artificial corneas in the treatment of corneal blindness, describe the different types of KPro and their indications. It will also review tissue needs from the eye bank, complications that may arise and research to improve outcomes focusing on ideas and projects that are most relevant to eye banking.

Management of corneal ectasia

Presenter: Shahzad I. Mian, MD

This presentation will discuss the evolving treatment strategies for the management of corneal ectasia.

Transitioning to DMEK with the DORC tube

Presenter: Parag A. Majmudar, MD

DMEK surgery can be daunting for surgeons when they first begin integrating it into their practice. But with the new preloaded DORC tube from Eversight, making the transition to DMEK surgery can be painless.